Population Genetics Technologies was established in 2005 by Nobel Laureate Sydney Brenner to commercialise elements of his extensive intellectual property portfolio. The company has developed revolutionary technologies for high sensitivity and high specificity next generation sequencing (NGS) detection of genetic variants, with a focus on its clinical implementation.


Projects we have worked on with this client will soon be featured below – if you would like to find out more in the meantime, please click here to contact us.